Document Detail

Self-treating hypoglycaemia: a longitudinal qualitative investigation of the experiences and views of people with Type 1 diabetes.
MedLine Citation:
PMID:  22946549     Owner:  NLM     Status:  MEDLINE    
AIMS:   Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for many people with Type 1 diabetes. Little attention has been paid to how individuals self-treat hypoglycaemia and their likes and dislikes of clinically recommended treatments. We explored participants' experiences of self-treating hypoglycaemia after attending a structured education programme for people with Type 1 diabetes. Our aims were: to identify treatments that are acceptable to people with Type 1 diabetes; and to provide recommendations for promoting self-treatment in line with clinical guidelines.
METHODS:   Thirty adults with Type 1 diabetes were recruited from the Dose Adjustment for Normal Eating (DAFNE) programme in the UK. Study participants were interviewed post-course and 6 and 12 months later, enabling their experiences to be explored over time.
RESULTS:   Study participants described a poor knowledge of how to self-treat hypoglycaemia correctly pre-course. Post-course, individuals often struggled to adhere to clinically recommended guidelines because of: panic, disorientation, hunger sensations and consequent difficulties ingesting fixed quantities of fast-acting carbohydrate; use of sweets to manage hypoglycaemia; reversion to habituated practices when cognitive impairment as a result of hypoglycaemia supervened; difficulties ingesting dextrose tablets; and other people's anxieties about under-treatment.
CONCLUSIONS:   Historical experiences of hypoglycaemia and habituated practices can influence present self-treatment approaches. Professionals need to be aware of the range of difficulties individuals may experience restricting themselves to fixed quantities of fast-acting carbohydrate to manage hypoglycaemia. There may be merit in developing a more acceptable range of treatments tailored to people's own preferences, circumstances and needs.
J Lawton; D Rankin; D D Cooke; J Elliott; S Amiel; S Heller;
Related Documents :
23430039 - What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
23467919 - Preoperatively determinable factors predictive of diabetes mellitus remission following...
24088099 - Glycemic management in a patient with type 2 diabetes.
23503099 - Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular e...
17345999 - Subjectivity and examiner experience in diagnosis of residual caries--an in vitro study.
23148189 - Noninvasive management of the diabetic foot with critical limb ischemia: current option...
9732339 - Cost effectiveness analysis of improved blood pressure control in hypertensive patients...
11210239 - Diabetes and vascular disease.
9437509 - Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetic medicine : a journal of the British Diabetic Association     Volume:  30     ISSN:  1464-5491     ISO Abbreviation:  Diabet. Med.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-22     Completed Date:  2013-07-29     Revised Date:  2014-11-05    
Medline Journal Info:
Nlm Unique ID:  8500858     Medline TA:  Diabet Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  209-15     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Diabetes Mellitus, Type 1 / blood,  psychology,  therapy*
Guidelines as Topic
Hypoglycemia / blood,  prevention & control*,  psychology
Hypoglycemic Agents / administration & dosage*
Insulin / administration & dosage*
Longitudinal Studies
Middle Aged
Patient Education as Topic / methods*
Patient Satisfaction
Qualitative Research
Self Care*
Social Support
Grant Support
RP-PG-0606-1184//Department of Health
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  IL-8 release from human neutrophils cultured with pro-haptenic chemical sensitizers.
Next Document:  Total Synthesis of Laetevirenol A.